Immunizations in Athletes

Abstract

Context:

Immunizations are a cornerstone of preventive care and an important consideration for team physicians caring for athletes.

Evidence Acquisition:

A PubMed search was performed from August 2016 through May 2017 as well as a website review of the Centers for Disease Control and Prevention, World Health Organization, and Immunization Action Coalition.

Study Design:

Clinical review.

Level of Evidence:

Level 4.

Results:

By keeping abreast of diseases endemic to nations to which athletes may be traveling as well as the vaccination status of the athletes, team physicians can provide appropriate advice regarding immunization and prevention of disease.

Conclusion:

There are a host of regularly updated reliable websites to assist the team physician in these recommendations.

Keywords

athletes immunization vaccination disease outbreak sports

Get full access to this article

View all access options for this article.

References

Australian Government Department of Health and Aging. The Australian Immunization Handbook. 10th ed. Canberra: Australian Government Department of Health and Aging; 2017. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part4~handbook10-4-14. Accessed May 2, 2017.

Beran

Peeters

Dewé

Raupachová

Hobzová

Devaster

J-M

. Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults. BMC Infect Dis. 2013;13:224.

Centers for Disease Control and Prevention. Cholera—Vibrio cholera infection. Vaccines. https://www.cdc.gov/cholera/vaccines.html. Accessed March 21, 2017.

Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Diptheria. https://www.cdc.gov/vaccines/pubs/pinkbook/dip.html. Accessed April 28, 2017.

Centers for Disease Control and Prevention. For parents: vaccines for your children. https://www.cdc.gov/vaccines/parents/index.html. Accessed May 1, 2017.

Centers for Disease Control and Prevention. Travelers’ health. Chapter 3. Infectious diseases related to travel. Hepatitis B. https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/hepatitis-b. Accessed April 27, 2017.

Centers for Disease Control and Prevention. Vaccines and immunizations. Possible side-effects from vaccines. https://www.cdc.gov/vaccines/vac-gen/side-effects.htm. Accessed April 28, 2017.

Centers for Disease Control and Prevention. Vaccine information statements. Yellow fever VIS. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/yf.html. Accessed April 28, 2017.

Centers for Disease Control and Prevention. Vaccines, medicine, advice. https://wwwnc.cdc.gov/travel. Accessed April 4, 2017.

10.

Chang

M-H

Chen

D-S

. Prevention of hepatitis B. Cold Spring Harb Perspect Med. 2015;5:a021493.

11.

Daly

Gustafson

. Public health recommendations for athletes attending sporting events. Clin J Sport Med. 2011;21:67-70.

12.

Gärtner

Meyer

. Vaccination in elite athletes. Sports Med. 2014;44:1361-1376.

13.

Geier

. Rubella vaccine and arthritic adverse reactions: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1998. Clin Exp Rheumatol. 2001;19:724-726.

14.

Harris

. Infectious disease in athletes. Curr Sports Med Rep. 2011;10:84-89.

15.

Huntington

Allison

Nair

. Emerging vector-borne diseases. Am Fam Physician. 2016;94:551-557.

16.

Immunization Action Coalition. Welcome. http://immunize.org/. Accessed May 1, 2017.

17.

Jacobsen

. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. June 2009. http://apps.who.int/iris/bitstream/10665/70180/1/WHO_IVB_10.01_eng.pdf. Accessed April 28, 2017.

18.

Jones

Lawrence

Payne Hallström

et al ; international team. International infectious disease surveillance during the London Olympic and Paralympic Games 2012: process and outcomes. Euro Surveill. 2013;18:20554.

19.

Karpinos

Rizzone

Cribbs

Roumie

. Low proportion of high school senior athletes receiving recommended immunizations. Phys Sportsmed. 2014;42:71-79.

20.

Kordi

Wallace

. Blood borne infections in sport: risks of transmission, methods of prevention, and recommendations for hepatitis B vaccination. Br J Sports Med. 2004;38:678-684.

21.

Krowchuk

Hunter

et al . Parents’ knowledge of the purposes and content of preparticipation physical examinations. Arch Pediatr Adolesc Med. 1995;149:653-657.

22.

Luke

d’Hemecourt

. Prevention of infectious diseases in athletes. Clin Sports Med. 2007;26:321-344.

23.

Manzoli

Ioannidis

Flacco

De Vito

Villari

. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012;8:851-862.

24.

Marin

Marti

Kambhampati

Jeram

Seward

. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137:e20153741.

25.

Marocho

Vildózola

Valencia

et al . Comparative study on the protective effect of two immunization schemes using a hepatitis B recombinant vaccine in vulnerable health science students. Rev Gastroenterol Peru. 2005;25:313-319.

26.

Mufson

. Antibody response of pneumococcal vaccine: need for booster dosing? Int J Antimicrob Agents. 2000;14:107-112.

27.

Nattiv

Puffer

Green

. Lifestyles and health risks of collegiate athletes: a multi-center study. Clin J Sport Med. 1997;7:262-272.

28.

Pipe

. International travel and the elite athlete. Clin J Sport Med. 2011;21:62-66.

29.

Plumb

Bulkow

Bruce

et al . Persistence of antibody to hepatitis A virus 20 years after receipt of hepatitis A vaccine in Alaska. J Viral Hepat. 2017;24:608-612.

30.

Rao

Mao

Motlekar

Fangcheng

Kadhe

. A review of immunogenicity and tolerability of live attenuated hepatitis A vaccine in children. Hum Vaccin Immunother. 2016;12:3160-3165.

31.

Rosić

Malićević

Medić

. Immune response to hepatitis B vaccine in elite athletes. Med Pregl. 2008;61:55-59.

32.

Savoy

. ACIP releases 2017 Childhood Immunization Recommendations. Am Fam Physician. 2017;95:260-261.

33.

Smith

Lombardo

Robinson

. The preparticipation evaluation. Prim Care. 1991;18:777-807.

34.

Stuurman

Marano

Bunge

De Moerlooze

Shouval

. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines—a systematic review. Hum Vaccin Immunother. 2016;13:724-736.

35.

Sugawara

Ohsuka

Taya

et al . Diarrhea as a minor adverse effect due to oral polio vaccine. Jpn J Infect Dis. 2009;62:51-53.

36.

Takla

Velasco

Benzler

. The FIFA Women’s World Cup in Germany 2011—a practical example for tailoring an event-specific enhanced infectious disease surveillance system. BMC Public Health. 2012;12:576.

37.

Trabacchi

Odone

Lillo

Pasquarella

Signorelli

. Immunization practices in athletes. Acta Biomed. 2015;86:181-188.

38.

Tingle

Mitchell

Grace

et al . Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet. 1997;349:1277-1281.

39.

Wilson

deWeber

Berry

Wilckens

. Cutaneous infections in wrestlers. Sports Health. 2013;5:423-437.

40.

World Health Organization. Media Centre. Hepatitis A. Fact sheets. http://www.who.int/mediacentre/factsheets/fs328/en/. Accessed March 21, 2017.

41.

World Health Organization. Media Centre. Human papillomavirus (HPV) and cervical cancer. http://www.who.int/mediacentre/factsheets/fs380/en/. Accessed April 28, 2017.

42.

World Health Organization. Poliomyelitis. What is vaccine-derived polio? http://who.int/features/qa/64/en/. Accessed May 2, 2017.

43.

Young

Marra

. A systematic review of intradermal influenza vaccines. Vaccine. 2011;29:8788-8801.